Duke University licenses technology developed in the Gersbach Lab to Editas Medicine, a startup company focused on therapeutic genome engineering. Read the release from Editas,Duke, and others.
December 1, 2014
Duke University licenses technology developed in the Gersbach Lab to Editas Medicine, a startup company focused on therapeutic genome engineering. Read the release from Editas,Duke, and others.